Spyre Therapeutics Inc. (SYRE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Spyre Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$99.75
+0.71% today
Market cap
$10.3B
Overall quality
—
Kronos AI 30-day
−10.9%
0 of 8 simulated paths end higher
Spyre Therapeutics Inc. (SYRE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $10.3B. It trades at $99.75, up 0.71% today. 14 analysts' average target of $122.00 implies +22.3% from today's price. Kronos AI's 30-day forecast is −10.9% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $122.00 |
| Low – high | $110.00 – $130.00 |
| Analysts | 14 |
| Upside to average | +22.3% |
Kronos AI 30-day forecast
| Expected close | $88.28 (−10.9%) |
| Likely range | −19.4% … −2.1% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.